Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

Potency values from the local lymph node assay: application to classification, labelling and risk assessment.

Loveless SE, Api AM, Crevel RW, Debruyne E, Gamer A, Jowsey IR, Kern P, Kimber I, Lea L, Lloyd P, Mehmood Z, Steiling W, Veenstra G, Woolhiser M, Hennes C.

Regul Toxicol Pharmacol. 2010 Feb;56(1):54-66. doi: 10.1016/j.yrtph.2009.08.016. Epub 2009 Sep 4. Review.

PMID:
19733604
[PubMed - indexed for MEDLINE]
2.

Skin sensitization testing in potency and risk assessment.

Kimber I, Basketter DA, Berthold K, Butler M, Garrigue JL, Lea L, Newsome C, Roggeband R, Steiling W, Stropp G, Waterman S, Wiemann C.

Toxicol Sci. 2001 Feb;59(2):198-208. Review.

PMID:
11158712
[PubMed - indexed for MEDLINE]
Free Article
3.

Classification of contact allergens according to potency: proposals.

Kimber I, Basketter DA, Butler M, Gamer A, Garrigue JL, Gerberick GF, Newsome C, Steiling W, Vohr HW.

Food Chem Toxicol. 2003 Dec;41(12):1799-809.

PMID:
14563405
[PubMed - indexed for MEDLINE]
4.

Use of the local lymph node assay for the estimation of relative contact allergenic potency.

Basketter DA, Balikie L, Dearman RJ, Kimber I, Ryan CA, Gerberick GF, Harvey P, Evans P, White IR, Rycroft RJ.

Contact Dermatitis. 2000 Jun;42(6):344-8.

PMID:
10871098
[PubMed - indexed for MEDLINE]
5.

The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.

Jowsey IR, Clapp CJ, Safford B, Gibbons BT, Basketter DA.

Cutan Ocul Toxicol. 2008;27(2):67-75. doi: 10.1080/15569520801904655.

PMID:
18568891
[PubMed - indexed for MEDLINE]
6.

Contact allergenic potency: correlation of human and local lymph node assay data.

Gerberick GF, Robinson MK, Ryan CA, Dearman RJ, Kimber I, Basketter DA, Wright Z, Marks JG.

Am J Contact Dermat. 2001 Sep;12(3):156-61.

PMID:
11526521
[PubMed - indexed for MEDLINE]
7.

Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.

Takeyoshi M, Iida K, Shiraishi K, Hoshuyama S.

J Appl Toxicol. 2005 Mar-Apr;25(2):129-34.

PMID:
15744759
[PubMed - indexed for MEDLINE]
8.

The local lymph node assay and the assessment of relative potency: status of validation.

Basketter DA, Gerberick F, Kimber I.

Contact Dermatitis. 2007 Aug;57(2):70-5. Review.

PMID:
17627643
[PubMed - indexed for MEDLINE]
9.

A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses.

Basketter DA, Lea LJ, Dickens A, Briggs D, Pate I, Dearman RJ, Kimber I.

J Appl Toxicol. 1999 Jul-Aug;19(4):261-6.

PMID:
10439340
[PubMed - indexed for MEDLINE]
10.

The local lymph node assay: past, present and future.

Kimber I, Dearman RJ, Basketter DA, Ryan CA, Gerberick GF.

Contact Dermatitis. 2002 Dec;47(6):315-28. Review.

PMID:
12581276
[PubMed - indexed for MEDLINE]
11.

Human potency predictions for aldehydes using the local lymph node assay.

Basketter DA, Wright ZM, Warbrick EV, Dearman RJ, Kimber I, Ryan CA, Gerberick GF, White IR.

Contact Dermatitis. 2001 Aug;45(2):89-94.

PMID:
11553118
[PubMed - indexed for MEDLINE]
12.

Extrapolating local lymph node assay EC3 values to estimate relative sensitizing potency.

Ryan CA, Chaney JG, Gerberick GF, Kern PS, Dearman RJ, Kimber I, Basketter DA.

Cutan Ocul Toxicol. 2007;26(2):135-45.

PMID:
17612980
[PubMed - indexed for MEDLINE]
13.

Quantitative relationship between the local lymph node assay and human skin sensitization assays.

Schneider K, Akkan Z.

Regul Toxicol Pharmacol. 2004 Jun;39(3):245-55.

PMID:
15135206
[PubMed - indexed for MEDLINE]
14.

The local lymph node assay: current position in the regulatory classification of skin sensitizing chemicals.

Basketter DA, Gerberick GF, Kimber I.

Cutan Ocul Toxicol. 2007;26(4):293-301.

PMID:
18058304
[PubMed - indexed for MEDLINE]
15.

Predictive identification of human skin sensitization thresholds.

Basketter DA, Clapp C, Jefferies D, Safford B, Ryan CA, Gerberick F, Dearman RJ, Kimber I.

Contact Dermatitis. 2005 Nov;53(5):260-7.

PMID:
16283904
[PubMed - indexed for MEDLINE]
16.

Skin sensitisation, vehicle effects and the local lymph node assay.

Basketter DA, Gerberick GF, Kimber I.

Food Chem Toxicol. 2001 Jun;39(6):621-7. Review.

PMID:
11346493
[PubMed - indexed for MEDLINE]
18.

Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay.

Dearman RJ, Betts CJ, Farr C, McLaughlin J, Berdasco N, Wiench K, Kimber I.

Contact Dermatitis. 2007 Oct;57(4):242-7.

PMID:
17868217
[PubMed - indexed for MEDLINE]
19.

Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.

Betts CJ, Dearman RJ, Heylings JR, Kimber I, Basketter DA.

Contact Dermatitis. 2006 Sep;55(3):140-7.

PMID:
16918612
[PubMed - indexed for MEDLINE]
20.

The local lymph node assay and skin sensitization testing.

Kimber I, Dearman RJ.

Methods Mol Biol. 2010;598:221-31. doi: 10.1007/978-1-60761-401-2_16.

PMID:
19967517
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk